Clinical Trials Directory

Trials / Sponsors / Quark Pharmaceuticals

Quark Pharmaceuticals

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
TerminatedEvaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery
Cardiac Surgery
—2020-02-21
TerminatedQPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Followi
Cardiac Surgery
Phase 32018-06-29
CompletedQPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Delayed Graft Function
Phase 32016-03-01
TerminatedPhase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic An
Non Arteritic Anterior Ischemic Optic Neuropathy
Phase 2 / Phase 32016-02-24
CompletedA Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Su
Acute Kidney Injury
Phase 22015-12-01
CompletedPhase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Inject
Glaucoma, Angle-closure, Primary, Acute
Phase 22013-12-01
CompletedPF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular
Choroidal Neovascularization, Diabetic Retinopathy, Diabetic Macular Edema
Phase 22012-02-01
CompletedSafety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patie
Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy
Phase 12010-02-01
CompletedPhase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucent
Age Related Macular Degeneration
Phase 22009-11-01
CompletedI5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Delayed Graft Function, Other Complication of Kidney Transplant
Phase 1 / Phase 22008-12-01
TerminatedStudy Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema
Diabetic Retinopathy, Diabetes Complications
Phase 22008-06-01
TerminatedA Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AK
Acute Renal Failure, Acute Kidney Injury
Phase 12008-05-01
CompletedA Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
Injury of Kidney, Acute Renal Failure
Phase 12007-08-01
CompletedStudy of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related M
Age-Related Macular Degeneration
Phase 12007-02-01